Skip to main content

Table 5 Patient characteristics

From: Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

Pt No.

Age

Gender

Disease stage

1

52

F

M1a

2

52

F

M1a

3

66

M

M1a

4

49

M

M1a

5

40

M

M1c

6

63

F

M1c